Here, we addressed the hypothesis that increasing plasma APN levels provides therapeutic benefit by inhibiting AngII-mediated vascular inflammation and atherosclerotic lesion development in a hypertensive and accelerated atherosclerosis LDLR−/− model [38]. The gene discussed is ANPEP; the disease is atherosclerosis.